Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect
several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex …

In this review, we provide an update on genome-wide association studies (GWAS) in
inflammatory bowel disease (IBD). In addition, we summarize progress in defining the functional …

Background The COVID-19 pandemic has claimed the lives of nearly 2 million people
worldwide. 1 Following rapid sequencing of SARS-CoV-2, pharmaceutical companies and …

We undertook a meta-analysis of six Crohn's disease genome-wide association studies (GWAS)
comprising 6,333 affected individuals (cases) and 15,056 controls and followed up the …

Decreases in the diversity of enteric bacterial populations are observed in patients with
Crohn's disease (CD) and ulcerative colitis (UC). Less is known about the virome in these …

The intestinal microflora, typically equated with bacteria, influences diseases such as obesity
and inflammatory bowel disease. Here, we show that the mammalian gut contains a rich …

More than 1,000 susceptibility loci have been identified through genome-wide association
studies (GWAS) of common variants; however, the specific genes and full allelic spectrum of …

Background Crohn's disease and ulcerative colitis are the two major forms of inflammatory
bowel disease; treatment strategies have historically been determined by this binary …

Ulcerative colitis is a chronic, relapsing inflammatory condition of the gastrointestinal tract
with a complex genetic and environmental etiology. In an effort to identify genetic variation …

Inflammatory bowel disease (IBD) is associated with risk variants in the human genome and
dysbiosis of the gut microbiome, though unifying principles for these findings remain largely …